Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Maintenance of Investigator Site File (ISF)

Posted on By

Standard Operating Procedure for Managing the Investigator Site File

Purpose

This SOP outlines the procedures for maintaining the Investigator Site File (ISF) in clinical trials and clinical studies. The goal is to ensure that all essential documents are organized, up-to-date, and readily accessible for monitoring, auditing, and regulatory inspections.

Scope

This SOP applies to all personnel involved in managing and maintaining the Investigator Site File (ISF) for clinical trials and clinical studies, including principal investigators, clinical research coordinators, and study support staff.

Responsibilities

  • Principal Investigator (PI): Ensures the ISF is maintained according to study requirements and regulatory standards.
  • Clinical Research Coordinators: Organize and maintain the ISF and ensure all essential documents are up-to-date.
  • Study Sponsors: Provide guidance and support for the maintenance of the ISF.
See also  SOP for Site Close-Out and Study Termination

Procedure

  • Organization and Contents of ISF:
    • Maintain the ISF according to the standard structure outlined in the study protocol and applicable regulations (e.g., ICH-GCP).
    • Include essential documents such as study protocols, informed consent forms, case report forms, and safety reports.
  • Document Management:
    • Ensure all documents in the ISF are clearly labeled and organized in a logical order.
    • Keep documents up-to-date and promptly file any new or revised documents.
    • Use version control for revised documents to track changes and maintain document history.
  • Access and Security:
    • Provide controlled access to the ISF to authorized personnel only.
    • Maintain the ISF in a secure location to prevent unauthorized access, loss, or damage.
  • Audit and Inspection Readiness:
    • Regularly review the ISF for completeness and accuracy to ensure audit and inspection readiness.
    • Address any discrepancies or missing documents promptly.
  • Record-Keeping:
    • Keep records of ISF maintenance activities, including reviews, updates, and document retrievals.
See also  SOP for Safety Monitoring and Reporting

Abbreviations Used

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator
  • ISF: Investigator Site File
  • ICH-GCP: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use – Good Clinical Practice

Documents

  • ISF structure and content list
  • Document version control logs
  • ISF review and audit logs

References

  • ICH-GCP guidelines
  • Institutional policies for ISF management

SOP Version

Version: 1.0

Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

Post navigation

Previous Post: SOP for Communication with Regulatory Authorities
Next Post: SOP for External Laboratory and Diagnostic Services

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version